feed,title,long_url,short_url
Benzinga,Novartis Terminates Three Beovu Studies in Ocular Disorders Citing Patient Safety,https://benzinga.com/general/biotech/21/06/21363350/novartis-terminates-three-beovu-studies-in-ocular-disorders-citing-patient-safety,https://j.mp/3yNNv0h
